Sumanta K. Pal: Subanalysis of patients in IMmotion010 with sarcomatoid features
Sumanta K. Pal, Kidney Cancer Professor at City of Hope shared an article by Jose Antonio Karam et al., on X:
Authors: Jose Antonio Karam, Robert Uzzo, Axel Bexe, William Leung, Connie Tat, Alan Nicholas, Alexander Andreev-Drakhlin, Mahrukh Huseni, Sumanta Kumar Pal, Viraj A. Master.
“Congrats to Dr. Jose Karam, MD Anderson Cancer Center and Viraj Master, Winship Cancer Institute of Emory University who drove this important subanalysis of patients in IMmotion010 who had sarcomatoid features. No statistically significant difference in DFS – curves shown below. So appreciative of Society of Urologic Oncology members like Jose and Viraj who really drove accrual to this trial.”
Source: Sumanta K. Pal/X
Sumanta (Monty) Pal, MD, is a medical oncologist and an expert in genitourinary cancers at the City of Hope Comprehensive Cancer Center in Los Angeles. He serves as the co-director of the Kidney Cancer Program and leads the Kidney and Bladder Cancer Disease Team at City of Hope. He specialises in kidney, bladder, and prostate cancers.